[go: up one dir, main page]

IN2012DN00767A - - Google Patents

Download PDF

Info

Publication number
IN2012DN00767A
IN2012DN00767A IN767DEN2012A IN2012DN00767A IN 2012DN00767 A IN2012DN00767 A IN 2012DN00767A IN 767DEN2012 A IN767DEN2012 A IN 767DEN2012A IN 2012DN00767 A IN2012DN00767 A IN 2012DN00767A
Authority
IN
India
Prior art keywords
therapy
initiation
tools
response
serum
Prior art date
Application number
Other languages
English (en)
Inventor
Visvanathan Sudha
Wagner Carrie
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of IN2012DN00767A publication Critical patent/IN2012DN00767A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/52Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving transaminase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • G01N2333/485Epidermal growth factor [EGF] (urogastrone)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/525Tumor necrosis factor [TNF]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70539MHC-molecules, e.g. HLA-molecules
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/91188Transferases (2.) transferring nitrogenous groups (2.6)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/101Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IN767DEN2012 2009-07-28 2010-07-12 IN2012DN00767A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22899409P 2009-07-28 2009-07-28
PCT/US2010/041714 WO2011014349A1 (fr) 2009-07-28 2010-07-12 Marqueurs sériques pour la prédiction de la réponse clinique à des anticorps anti-tnfα chez des patients atteints de psoriasis arthropathique

Publications (1)

Publication Number Publication Date
IN2012DN00767A true IN2012DN00767A (fr) 2015-06-26

Family

ID=43529642

Family Applications (1)

Application Number Title Priority Date Filing Date
IN767DEN2012 IN2012DN00767A (fr) 2009-07-28 2010-07-12

Country Status (7)

Country Link
US (1) US20120178100A1 (fr)
EP (1) EP2460007A4 (fr)
CN (1) CN102576015B (fr)
AU (1) AU2010276665A1 (fr)
CA (1) CA2769462A1 (fr)
IN (1) IN2012DN00767A (fr)
WO (1) WO2011014349A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3384939A1 (fr) 2011-03-11 2018-10-10 Vib Vzw Molécules et procédés pour l'inhibition et la détection de protéines
CN104011223A (zh) * 2011-11-21 2014-08-27 诺华股份有限公司 使用il-17拮抗剂及psa应答或非应答等位基因治疗银屑病性关节炎(psa)的方法
FR3010188B1 (fr) * 2013-09-05 2017-11-24 Univ Joseph Fourier - Grenoble 1 Procede theragnostique pour le traitement des rhumatismes inflammatoires chroniques
CA3000192C (fr) * 2015-09-29 2023-09-26 Crescendo Bioscience Biomarqueurs et procedes d'evaluation de l'activite de la maladie arthrite psoriasique
JP6751157B2 (ja) * 2016-05-12 2020-09-02 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 疾患を治療するために標的へ向けられた薬物の効力を予測するためのシステム
CN109580759A (zh) * 2017-09-28 2019-04-05 成都飞机工业(集团)有限责任公司 一种四极质谱计
US11232344B2 (en) 2017-10-31 2022-01-25 General Electric Company Multi-task feature selection neural networks
WO2019173283A1 (fr) 2018-03-05 2019-09-12 Marquette University Procédé et appareil de prédiction du niveau d'hémoglobine non invasifs
IL284794B2 (en) * 2019-01-23 2025-10-01 Janssen Biotech Inc Anti-TNF antibody preparations for use in methods of treating psoriatic arthritis
CN114518416B (zh) * 2020-11-20 2024-05-24 上海交通大学医学院附属瑞金医院 一种判断银屑病对il-17a抗体应答反应及其复发的标志物
AU2021402149A1 (en) * 2020-12-18 2023-07-13 Nightingale Health Oyj Method for determining whether a subject is at risk of developing a musculoskeletal and/or connective tissue disease
CA3208411A1 (fr) * 2021-02-25 2022-09-01 George C. Lee Quantification et evaluation de topologie de biomarqueur basees sur une reponse de patient pour de multiples types de tissu

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030154032A1 (en) * 2000-12-15 2003-08-14 Pittman Debra D. Methods and compositions for diagnosing and treating rheumatoid arthritis
WO2007123976A2 (fr) * 2006-04-18 2007-11-01 The Board Of Trustees Of The Leland Stanford Junior University Établissement de profils d'anticorps pour la détermination de la sensibilité des patients à un traitement
PT2571532T (pt) * 2010-05-14 2017-08-04 Abbvie Inc Proteínas de ligação a il-1

Also Published As

Publication number Publication date
WO2011014349A1 (fr) 2011-02-03
US20120178100A1 (en) 2012-07-12
CN102576015A (zh) 2012-07-11
EP2460007A4 (fr) 2013-06-19
AU2010276665A1 (en) 2012-02-23
EP2460007A1 (fr) 2012-06-06
CA2769462A1 (fr) 2011-02-03
CN102576015B (zh) 2014-09-10

Similar Documents

Publication Publication Date Title
IN2012DN00767A (fr)
WO2019213282A8 (fr) Biomarqueurs pour évaluer des cellules car-t pour prédire un résultat clinique
MX2018012580A (es) Métodos y kits para el diagnóstico y la estratificación de riesgo en pacientes con isquemia.
BR112014031365A2 (pt) métodos de detectar doenças ou condições
BR112015025407A2 (pt) método e dispositivo para testar um transformador
EP3839510A3 (fr) Biomarqueurs sanguins de la sensibilité d'une tumeur à des antagonistes de pd-1
WO2008036835A3 (fr) Procédés et compositions permettant la régulation à la hausse de l'activité de la peroxirédoxine
EA201690213A1 (ru) Композиции и способ лечения связанных с комплементом состояний
BR112018003300A2 (pt) sistemas e métodos para determinar informação relacionada a uma ordem atual com base em ordens históricas
BR112015004631A2 (pt) marcadores genéticos de resistência à mastite
BR112015029852A2 (pt) método para prever ou monitorar se um paciente que sofre de câncer ou uma doença autoimune responderá ou responde ao tratamento com um agonista de tlr-9, agonista de tlr-9 para uso em um método de tratamento de câncer, e kit para prever ou monitorar se um paciente que sofre de câncer ou doença autoimune irá responder ou responde ao tratamento com um agonista de tlr-9
BR112012024175A2 (pt) hbf e a1m como marcadores de estágio precoce para preeclampsia
MX2014011045A (es) Metodo para seleccionar o identificar un sujeto para la terapia antagonista vib.
BR112013025287A2 (pt) ensaios com receptores de esteroide para detectar células tumorais
BR112021021574A2 (pt) Método para identificar uma abordagem reprodutiva em um indivíduo que sofre de uma varicocele
UA108284U (uk) Спосіб прогнозування розвитку остеопорозу
UA109274U (uk) Спосіб прогнозування розвитку остеопорозу
UA128823U (uk) Спосіб прогнозування розвитку остеоартрозу
UA108612U (uk) Спосіб прогнозування розвитку остеопорозу
UA108263U (uk) Спосіб прогнозування розвитку остеопорозу
UA82147U (ru) Способ прогнозирования риска возникновения ишемического инсульта
Morin et al. Advanced paternal age does not affect embryo development in preimplantation genetic screening cycles
UA108259U (uk) Спосіб прогнозування розвитку остеопорозу
UA108281U (uk) Спосіб прогнозування розвитку остеопорозу
UA95627U (uk) Спосіб прогнозування зрощення перелому